These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1384501)

  • 1. Inhibition of reverse transcriptase from feline immunodeficiency virus by analogs of 2'-deoxyadenosine-5'-triphosphate.
    Cronn RC; Remington KM; Preston BD; North TW
    Biochem Pharmacol; 1992 Oct; 44(7):1375-81. PubMed ID: 1384501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound.
    Balzarini J; Hao Z; Herdewijn P; Johns DG; De Clercq E
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1499-503. PubMed ID: 1705039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
    Ueno T; Mitsuya H
    Biochemistry; 1997 Feb; 36(5):1092-9. PubMed ID: 9033399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of HIV-1 reverse transcriptase by an antiviral inhibitor, (R)-9-(2-Phosphonylmethoxypropyl)adenine.
    Suo Z; Johnson KA
    J Biol Chem; 1998 Oct; 273(42):27250-8. PubMed ID: 9765248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
    Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
    Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo.
    Balzarini J; Holy A; Jindrich J; Dvorakova H; Hao Z; Snoeck R; Herdewijn P; Johns DG; De Clercq E
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4961-5. PubMed ID: 1711214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.
    Perno CF; Balestra E; Aquaro S; Panti S; Cenci A; Lazzarino G; Tavazzi B; Di Pierro D; Balzarini J; Calio R
    Mol Pharmacol; 1996 Aug; 50(2):359-66. PubMed ID: 8700144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.
    Tramontano E; Cheng YC
    Biochem Pharmacol; 1992 Mar; 43(6):1371-6. PubMed ID: 1373283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative kinetic analyses of interaction of inhibitors with Rauscher murine leukemia virus and human immunodeficiency virus reverse transcriptases.
    Cherrington JM; Fuller MD; Mulato AS; Allen SJ; Kunder SC; Ussery MA; Lesnikowski Z; Schinazi RF; Sommadossi JP; Chen MS
    Antimicrob Agents Chemother; 1996 May; 40(5):1270-3. PubMed ID: 8723481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus-specified DNA polymerase is the target for the antiviral action of 9-(2-phosphonylmethoxyethyl)adenine.
    Foster SA; Cerny J; Cheng YC
    J Biol Chem; 1991 Jan; 266(1):238-44. PubMed ID: 1845964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by 3'-blocked oligonucleotide primers.
    Austermann S; Kruhøffer M; Grosse F
    Biochem Pharmacol; 1992 Jun; 43(12):2581-9. PubMed ID: 1378738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro.
    Holý A; Votruba I; Merta A; Cerný J; Veselý J; Vlach J; Sedivá K; Rosenberg I; Otmar M; Hrebabecký H
    Antiviral Res; 1990 Jun; 13(6):295-311. PubMed ID: 1699493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 reverse transcriptase expressing the K70E mutation exhibits a decrease in specific activity and processivity.
    Miller MD; Lamy PD; Fuller MD; Mulato AS; Margot NA; Cihlar T; Cherrington JM
    Mol Pharmacol; 1998 Aug; 54(2):291-7. PubMed ID: 9687570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors.
    Auwerx J; North TW; Preston BD; Klarmann GJ; De Clercq E; Balzarini J
    Mol Pharmacol; 2002 Feb; 61(2):400-6. PubMed ID: 11809865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2',3'-dideoxycytidine.
    Medlin HK; Zhu YQ; Remington KM; Phillips TR; North TW
    Antimicrob Agents Chemother; 1996 Apr; 40(4):953-7. PubMed ID: 8849258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
    Tanabe T; Yamamoto JK
    J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct comparisons of inhibitor sensitivities of reverse transcriptases from feline and human immunodeficiency viruses.
    North TW; Cronn RC; Remington KM; Tandberg RT
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1505-7. PubMed ID: 1699491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
    Auwerx J; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine.
    Egberink H; Borst M; Niphuis H; Balzarini J; Neu H; Schellekens H; De Clercq E; Horzinek M; Koolen M
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3087-91. PubMed ID: 2158102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of adenylyl cyclase by acyclic nucleoside phosphonate antiviral agents.
    Shoshani I; Laux WH; Périgaud C; Gosselin G; Johnson RA
    J Biol Chem; 1999 Dec; 274(49):34742-4. PubMed ID: 10574942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.